This week, MedMen (MMEN.C) attempted to shine a light on a wall to distract folks from their ongoing lawsuits and revelations of free spending, bonus-enriched execs, by revealing a…
IAN.C
People sometimes ask me for advice. The two questions I’m asked most are, ‘What stock is going up next’ and ‘Why should I listen to you?’ The answer to…
On February 20, 2019 iAnthus Capital Holdings (IAN.C) announced that it has opened a 2nd New York dispensary, Citiva Hudson Valley – located in the Dutchess County town of…
Ianthus Capital Holdings (IAN.C) has expanded its reach over the United States cannabis markets with the acquisition of MPX Bioceutical. MPX Bioceutical is a vertically-integrated multinational company operating in…
Back in the day, Over-the-Counter (OTC) stocks (“pink sheets) were to regulated markets – what Harvey Weinstein is now to gender relations. Unsavory. Unscrupulous. Immoral. In the 1970s, mafia…
On January 15, 2019 – at the somewhat unusual time of 6 p.m. EST, iAnthus Capital (IAN.C) and MPX Bioceutical (MPX.C) jointly announced that MPX holders had voted overwhelmingly…
On January 7, 2019 iAnthus Capital (IAN.C) announced the successful opening of its flagship dispensary in Brooklyn, New York, (pop. 2.6 million). “Brooklyn is arguably the birthplace of every…
As Canadian-based marijuana companies pivot from selling sizzle to selling steak – there has been a macro weed-sector stock-price slump. The Canadian Marijuana Index – flying high at 858…
One thing I love about US-focused cannabis roll-up C21 Investments (CXXI.C) is their ‘coming through’ attitude. They’re buying up US weed assets quickly, and don’t mess around with small…
On October18, 2018 iAnthus Capital (IAN.C) announced a deal to “combine with MPX” in an all-stock transaction valued at $835 million. MPX is a vertically integrated cannabis operation providing…